glp-1 shot-tracking app funding Tracker Shotsy - GLP-1 Tracker -

CMS is proposing temporary expansions of Medicare and Medicaid coverage of GLP-1s for obesity through demonstration programs CMS initially proposed a two-step approach to expanding coverage of GLP-1s for obesity in Medicare a temporary payment demonstration for 2026, known as the Medicare GLP-1 Bridge, and a new Center for Medicare and Medicaid Innovation (CMMI) model, known as the BALANCE Model, that was originally scheduled to begin in January 2027 and end in December 2031

Strength Well Best for Maintaining Strength One of the most important things a GLP-1 user can do alongside their medication is resistance train

GLP-1 receptor agonists are a class of prescription medications that essentially function the same way as GLP-1 produced in the body

Certain GLP-1 drugs also have proven benefits for people with CKD, OSA, or liver disease

Get this step right, and every dose that follows is accurate